Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/29/2009WO2009059806A3 Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine
10/29/2009WO2009043355A3 SYSTEMIC PRO-HEMOSTATIC EFFECT OF SYMPATHICOMIMETICS WITH AGONISTIC EFFECTS ON α-ADRENERGIC AND/OR β-ADRENERGIC RECEPTORS OF THE SYMPATHETIC NERVOUS SYSTEM, RELATED TO IMPROVED CLOT STRENGTH
10/29/2009WO2009041799A9 Pharmaceutical composition combining diacerein and chondroitin sulphate and use thereof in the treatment of osteoarthritis and related diseases
10/29/2009WO2009039461A3 N-substituted piperidine derivatives as serotonin receptor agents
10/29/2009WO2009035951A3 Soluble epoxide hydrolase inhibitors
10/29/2009WO2009021121A4 Identification and characterization of hcv replicon variants with reduced susceptibility to a combination of polymerase and protease inhibitors, and methods related thereto
10/29/2009WO2009013237A3 Stable solid pharmaceutical composition comprising candesartan or pharmaceutically acceptable forms thereof
10/29/2009WO2008148018A3 Rapidly dispersible vaginal tablet that provides a bioadhesive gel
10/29/2009WO2008124575A8 Renin inhibitors
10/29/2009WO2008122119A8 Perfluoroketone compounds and uses thereof
10/29/2009WO2008088987A9 Treatment of pain with naloxone
10/29/2009WO2007146602A8 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
10/29/2009US20090271879 Analogues of (-)-picropodophyllin, synthesis and uses thereof
10/29/2009US20090270881 Facial blemish removing device
10/29/2009US20090270859 Fluid compositions and methods for the use thereof
10/29/2009US20090270634 hydrolyzing the brominated product of 1-methylhydantoin to form 5-hydroxy-1-methylimidazolidin-2,4-dione, drug such as for renal failure; purified product for renal patients
10/29/2009US20090270613 5-Fluoro-4-methyl-2-{2-[4-(4-methyl-piperazin-1-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; leukocyte recruitment inhibition, modulating H4 receptor, and treating conditions such as inflammation
10/29/2009US20090270611 Benzoimidazole compounds
10/29/2009US20090270592 Purified TNFR preparations
10/29/2009US20090270513 3,5-dihydroxy-2,4-cyclohexadienones and their derivatives, dietary compositions and fortified food containing them and their uses
10/29/2009US20090270512 Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal
10/29/2009US20090270511 Prodrugs of inhibitors of cathepsin s
10/29/2009US20090270510 Glycine transport inhibitors
10/29/2009US20090270509 Nitric oxide-releasing molecules
10/29/2009US20090270508 GluR2 receptor modulators
10/29/2009US20090270507 Concentrated Liquid Thyroid Hormone Composition
10/29/2009US20090270506 Crystalline structure of oxidosqualene synthase
10/29/2009US20090270505 4-dimethylaminobutyric acid derivatives
10/29/2009US20090270504 Treatment of Huntington's Disease With EPA
10/29/2009US20090270503 Nutritional supplements
10/29/2009US20090270502 Method for Lowering Risk of Cardiovascular Diseases
10/29/2009US20090270501 Composition and method for increasing the anabolic state of muscle cells
10/29/2009US20090270500 4-trimethylammonio-butyrates as cpt2 inhibitors
10/29/2009US20090270499 Process for Synthesizing Atazanavir
10/29/2009US20090270498 Lipoxin Compounds and Their use in Treating Cell Proliferative Disorders
10/29/2009US20090270497 Treatment of Non-Localized Inflammation with pan-HDAC Inhibitors
10/29/2009US20090270496 Antifungal compounds
10/29/2009US20090270495 Inhibitors of Phosphodiesterase Types 1 To 5 Based on Dioclein, Floranol, and Analogs Thereof
10/29/2009US20090270494 Salts of Dihydroxyanthraquinone Carboxylic Acids and Their Therapeutic Use
10/29/2009US20090270493 prodrugs of gabapentin and pregabalin, such as 2-[1-[[[(2R)-6-oxooxan-2-yl]oxycarbonylamino]methyl]cyclohexyl]aceticacid, used for for treating epilepsy, depression, anxiety, psychosis, brain disorders, neurodegenerative diseases, pain, inflammatory disease, gastrointestinal disorders or drug abuse
10/29/2009US20090270492 Bryostatin analogues, synthetic methods and uses
10/29/2009US20090270491 Modulation of tudor-sn expression
10/29/2009US20090270490 Methods involving aldose reductase inhibition
10/29/2009US20090270489 Long-acting polypeptides and methods of producing same
10/29/2009US20090270488 Process for the Selection of HIV-1 Subtype C Isolates, Selected HIV-1 Subtype Isolates, Their Genes and Modifications and Derivatives Thereof
10/29/2009US20090270487 A matrix metalloproteinase 1 siRNA molecule comprising SEQ ID NO:1 and SEQ ID NO:2; collengenase; enzyme inhibitors; antitumor agents; anticarcinogenic agents; antimetastatic agents; antisense therapy
10/29/2009US20090270486 Human rnase iii and compositions and uses thereof
10/29/2009US20090270485 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
10/29/2009US20090270483 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells
10/29/2009US20090270482 Analysis of methylated nucleic acid
10/29/2009US20090270481 MODIFIED siRNA MOLECULES AND USES THEREOF
10/29/2009US20090270480 Markers and Methods for Assessing and Treating Psoriasis and Related Disorders
10/29/2009US20090270479 Genetic and Epigenetic Alterations In the Diagnosis and Treatment of Cancer
10/29/2009US20090270478 Ion channel modulating activity ii
10/29/2009US20090270477 Polymorphs of a hydroisoindoline tachykinin receptor antagonist
10/29/2009US20090270476 Pharmaceutical composition for treatment or prevention of nephritis and manufacturing method thereof
10/29/2009US20090270474 Therapeutic Agent for Keratoconjunctival Disorder
10/29/2009US20090270473 Dual-acting antihypertensive agents
10/29/2009US20090270472 Method to use oxymetazoline to interrupt the development of the common cold syndrome
10/29/2009US20090270470 Compounds I
10/29/2009US20090270469 Substituted oxazolidinones
10/29/2009US20090270468 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
10/29/2009US20090270467 5-[(1S,3S,4R)-3-Amino-4-(2,4,5-trifluorophenyl)cyclohexyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-amine, used for treating insulin resistance, hyperglycemia and non-insulin dependent diabetes in mammals
10/29/2009US20090270466 Epothilones C, D, E, and F, Preparation and Compositions
10/29/2009US20090270465 Use of epothilone d in treating tau-associated diseases including alzheimer's disease
10/29/2009US20090270464 Benzimidazole derivative and use as a II receptor antagonist
10/29/2009US20090270463 Amido derivatives-contained pharmaceutical composition
10/29/2009US20090270462 2-sulfanyl-substituted imidazole derivatives and their use as cytokine inhibitors
10/29/2009US20090270460 Fxr agonists
10/29/2009US20090270458 Method of treating of demyelinating diseases or conditions
10/29/2009US20090270457 6,11-bicyclolides: bridged biaryl macrolide derivatives
10/29/2009US20090270456 Novel chemical compounds
10/29/2009US20090270455 Therapeutic agent for intestinal diseases and visceral pain
10/29/2009US20090270454 Sulfonamide containing compounds for treatment of inflammatory disorders
10/29/2009US20090270453 Anti-manic effective doses of sertindole
10/29/2009US20090270452 Use of soluble epoxide hydrolase inhibitors in the treatment of smooth muscle disorders
10/29/2009US20090270451 Piperdine Glycine Transporter Inhibitors
10/29/2009US20090270450 Chemical compounds
10/29/2009US20090270449 Aminophenyl derivatives as selective androgen receptor modulators
10/29/2009US20090270448 Pharmaceutical formulations comprising clopidogrel
10/29/2009US20090270447 2-Aryl-and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof
10/29/2009US20090270446 Diamine derivatives
10/29/2009US20090270445 Thiazole compounds and methods of use
10/29/2009US20090270444 1,7-Naphthyridines
10/29/2009US20090270443 1-amino imidazo-containing compounds and methods
10/29/2009US20090270442 Polymorphs of hydrochloride salt of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide and methods of use therefor
10/29/2009US20090270441 Macrolides
10/29/2009US20090270440 Bioavailability of active substances having an amidine function in medicaments
10/29/2009US20090270439 Prophylactic/therapeutic agent for alzheimer's disease
10/29/2009US20090270438 Novel compositions and formulations
10/29/2009US20090270437 Use of Buprenorphine or N-Alkylated Derivatives Thereof for Wound Healing
10/29/2009US20090270436 Spirochromanon derivatives
10/29/2009US20090270435 Spiroketone Acetyl-CoA Carboxylase Inhibitors
10/29/2009US20090270434 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/29/2009US20090270433 2,3-dihydro-iminoisoindole derivatives
10/29/2009US20090270432 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5-AMINE
10/29/2009US20090270431 Cyclopentenol Nucleoside Compounds Intermediates for their Synthesis and Methods of Treating Viral Infections
10/29/2009US20090270430 Pyridopyrimidinone Inhibitors of Pl3Kalpha
10/29/2009US20090270429 Antiviral formulation
10/29/2009US20090270428 Cyclopropanecarboxylate esters of acyclovir
1 ... 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 ... 7860